chrisvoncsefalvay/vaers-outcomes huggingface dataset:
If I lay down at night it pain on the left shoulder; Arm was hurting a lot and was hot; feeling really bad; She would fall back on the couch or whatever; Whole lot of pain in my left arm; it's just so sore that I can't lift it up, place close; Whole lot of pain in my left arm; it's just so sore that I can't lift it up, place close; This is a spontaneous report from a contactable consumer or other non hcp.    A 63-years-old female patient received bnt162b2 (BNT162B2), dose 2 via an unspecified route of administration, administered in Arm Left on 30Mar2021 (Batch/Lot Number: ER8732; Expiration Date: 31Jul2021) as 2nd dose, single for covid-19 immunisation. Medical history included hypertension, blood cholesterol, depression, thyroid disorder, seasonal allergy. Concomitant medication(s) included clonidine hydrochloride (CLONIDINE HCL) taken for hypertension; amlodipine (AMLODIPINE) taken for hypertension; atorvastatin (ATORVASTATIN) taken for blood cholesterol; doxepin (DOXEPIN) taken for depression, anxiety; ezetimibe (EZETIMIBE) taken for blood cholesterol; gabapentin (GABAPENTIN) taken for depression, anxiety; lamotrigine (LAMOTRIGINE) taken for depressed mood; levothyroxine (LEVOTHYROXINE) taken for thyroid disorder; hydrochlorothiazide, lisinopril (LISINOPRIL/HYDROCHLOROTHIAZIDE) taken for hypertension; montelukast (MONTELUKAST) taken for seasonal allergy; quetiapine (QUETIAPINE) taken for depression; sertraline (SERTRALINE) taken for depression; metoprolol (METOPROLOL) taken for hypertension.  It was Reported that, The patient experienced whole lot of pain in my left arm; it's just so sore that can't lift it up, place close on 30Mar2021 with outcome of not recovered, if  lay down at night it pain on the left shoulder on an unspecified date with outcome of unknown, arm was hurting a lot and was hot on an unspecified date with outcome of unknown , feeling really bad on an unspecified date with outcome of unknown , she would fall back on the couch or whatever on an unspecified date with outcome of unknown. Therapeutic measures were taken as a result of whole lot of pain in my left arm; it's just so sore that i can't lift it up, place close (limb discomfort), if i lay down at night it pains on the left shoulder (arthralgia).  No follow-up attempts are possible. No further information is expected.
Arm is so sore; Can barely move the arm; This is a spontaneous report from a contactable healthcare professional. A 57-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: 320380) via intramuscular route of administration in the left arm on 01Nov2021 at 16:00 (at the age of 57-years-old) as a single dose for COVID-19 immunisation. It was unknown if the patient had any medical history and known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications were not reported. On 01Nov2021 at 18:00, the patient's arm was so sore and on 03Nov2021, the patient had to stay home from work. The patient could barely move the arm. The patient was using a heating pad for soreness. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were taken as a result of the events and included treatment with heating pad. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events arm is so sore and can barely move the arm was not resolved at the time of this report.
Cough, low-grade fever, lethargy, body aches, stomach upset and hives.
Moderna COVID-19 Vaccine EUA.   Symptoms: Redness, swelling, arm pain, around injection site. Headache, chills, cold, sweats,
presented pain in her arm from her shoulder to her wrist; presented pain in her arm from her shoulder to her wrist; she feels fatigue; she developed a lump in her armpit that is really painful; she developed a lump in her armpit that is really painful; she feels numbness in her arm; This is a spontaneous report from a contactable consumer (patient). A female patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, solution for injection, Batch/Lot number was not reported), via an unspecified route of administration on an unspecified date as dose number unknown, single for covid-19 immunization. The patient medical history and concomitant medications were not reported. on an unspecified date following vaccination, the patient experienced presented pain in her arm from her shoulder to her wrist, fatigue, she developed a lump in her armpit that is really painful, and she feels numbness in her arm. These events resulted in the emergency room visit. The patient was informed that they were side effects due to vaccination, and if the events persisted, she would be required to visit emergency room again or visit her physician. The outcome of the events was unknown at the time of report.   No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Swelling of the lymph node in the armpit of the left arm where the shot was given.  It is uncomfortable, but know it will go away with time.
This case was reported by a nurse and described the occurrence of possible overdose in a 5-month-old male patient who received KINRIX (batch number 54L2R, expiry date 23rd September 2016). On 17th October 2014 13:00, the patient received KINRIX (injection) .5 ml. On an unknown date, an unknown time after receiving KINRIX, the patient experienced possible overdose, inappropriate age at vaccine administration and wrong vaccine administered. On an unknown date, the outcome of the possible overdose, inappropriate age at vaccine administration and wrong vaccine administered were unknown. It was unknown if the reporter considered the possible overdose, inappropriate age at vaccine administration and wrong vaccine administered to be related to KINRIX. Additional information received: No adverse reactions were reported at time of report.
"Covid arm" - red, itchy rash on upper left arm, tender muscles on upper left arm. Developed 11 days after injection. Tenderness different than initial sore arm from injection - more tender to touch, and not sore with movement/use. No treatment. 90% resolved 6 days after onset.
The first adverse event I assume has to do with Gardasil. My periods usually last 3-4 days and my last 2 periods since receiving the vaccine have lasted up to 10 days. I am currently on day 9 with no signs of an end. I have also been experiencing pain in my left arm and shoulder and have not been hurt there by being hit or falling or otherwise. The pain is from my elbow up to my shoulder and hurts worse on my shoulder and near where my shoulder bone and clavical bone touch. I am calling my doctor on Monday to report these effects as well.
Symptoms: SkinRash & UrticariaPruritus. Treatment: PREDNISONE 2 TAB ONCE, DIPHENHYDRAMINE 1 TAB ONCE.
feel weak; dizzy; acute numbness in both legs running up my feet to my knees - all balance - could not stand without assistance.; acute numbness in both legs running up my feet to my knees - all balance - could not stand without assistance/partial numbness in the face; This is a spontaneous report from a contactable consumer (patient). A 69-years-old male patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, lot number and expiration date unknown), via an unspecified route of administration in the left arm on 19Feb2021 at 14:00 as a single dose for COVID-19 immunization. Medical history included bladder cancer. The patient had no known allergies. The patient's concomitant medications were not reported. The patient previously received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration in the left arm on 29Jan2021 at 14:00 for COVID-19 immunization. The patient had no other vaccine in four weeks. Exactly two weeks after the second dose was administered (on 05Mar2021), the patient started to feel weak and dizzy and experienced acute numbness in both legs running up to his feet to his knees - all balance - could not stand without assistance, with partial numbness in the face. These progressively got worse for several days until disappearing on 12Mar2021. The patient had no COVID prior to vaccination and had not tested post-vaccination. No treatment was administered for the events. The patient recovered from the events on 12Mar2021. The adverse events (AE) resulted in: disability or permanent damage.  Information on the batch/lot number has been requested.
This spontaneous report as received from a medical assistance refers to a 66 year old patient of unknown gender. There was no information about the patient's concurrent conditions, concomitant therapies or medical history provided. On 15-APR-2016, the patient was vaccinated with an improperly stored dose of PNEUMOVAX 23 (lot # L018503, expiration date: 16-MAR-2017) (dose and route of administration were not reported). There was no adverse events reported. This is one of several reports received from the same reporter. Additional information has been requested.
I got a flu shot in my right arm and pneumonia shot in my left arm. Extreme chills, muscle aches, and headaches developed and progressed from 2PM on.  Subsequently fever kicked by 5PM (when I could check it) and rose to 103.3 (by 8PM).  Checked into ER around 9PM with a 102+ fever and remained there until 6AM, receiving Tylenol and fluids.  Injection site on my left arm (pneumonia) was incredibly red and sore by the 10/11AM, prior to onset of other symptoms.  The site (1 4-square inch blotch and another 3-square inch blotch below) was red, sore, hard, swollen, and extremely sensitive to the touch until 10/15.
Two days after the vaccine, my right foot started to feel weird - felt wet sometimes or felt tingly. My foot was not swollen. I still have those weird sensations 18 days after getting the vaccine.  Also, I had many small blood clots during my first menstruation after the vaccine (13 days after vaccine), which is not normal for me.
Expired Bexsero admnistered; This case was reported by a other health professional via call center representative and described the occurrence of expired vaccine used in a 17-year-old female patient who received Men B NVS (Bexsero) (batch number ABXB34AA, expiry date 31st July 2022) for prophylaxis.   Co-suspect products included meningococcal B recom vaccine + aloh + omv pre-filled syringe device (Bexsero Pre-Filled Syringe Device) injection syringe for prophylaxis.   On 1st August 2022, the patient received the 2nd dose of Bexsero and Bexsero Pre-Filled Syringe Device. On 1st August 2022, unknown after receiving Bexsero and Bexsero Pre-Filled Syringe Device, the patient experienced expired vaccine used. On an unknown date, the outcome of the expired vaccine used was unknown.   This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.   Additional Information: GSK receipt date: 12-Aug-2022 Reporter's comment: The clinic manager stated that Bexsero was administered to a patient 1 day after the expiration date. The reporter consented to follow-up via postal. Additional supportive information: The patient received an expired dose of Besero, which led to expired vaccine used. The case was linked with case US2022118576, reported by same reporter for different patient.; Sender's Comments:  US-GSK-US2022118576:Same reporter
Pt had worsening cough and congestion over the past 2 weeks.  Admitted for acute hypoxic respiratory failure and COVID-19.
Site: Pain at Injection Site-Severe, Site: Swelling at Injection Site-Medium, Additional Details: Patient experienced extreme pain in her left arm since her vaccination in November. Area is swollen, and marked with round circle. Patient has trouble lifting her arm. Confirmed over the phone that it was not SIRVA- vaccine was administered in mid arm, not too high to shoulder.
Patient c/o lightheadness, 5 minutes after second dose of Moderna Vaccine
15 yo developed herpes zoster in T3 dermatome. He has no history of varicella disease. He received VARIVAX at 12 months and 12yrs of age.
Anaphylaxis 10 min after MMR, VZV, HAV boosters.  Treated with Epinephrine 0.2mg SQ x2, Prednisolone PO 30mg, Benadryl 19mg PO.  911 to ER.
(L) thigh edema - ice, ibuprofen. Redness, very enlarged limb to knee w/ possible effusion at knee. Similar rxn with dose in 2012.
cough, wheezing, shortness of breath, nasal congestion, runny nose, fatigue, diarrhea, abdominal cramps, body aches, decreased smell with positive PCR on 08/03/2021
4/13/13 AM small red dime size area at injection site only. 4/14/13 AM silver dollar size raised itchy area surrounded by puffy redness. Redness continued to enlarge to entire back of arm from armpit to elbow was itchy and hot to touch. Began to finally subside 4/18/13.
Patient reports pain in arm that radiates into her back, reports that pain is so intense she can't move her arm
This spontaneous report was received from a medical assistant concerning, multiple, unspecified patients' of unknown age and gender. The patients medical history, concurrent conditions and concomitant therapies were not reported. On an unknown dates, the patients were vaccinated with an improperly stored doses of RECOMBIVAX HB (lot number: M020926, expiration date: 11-AUG-2018) (dose and route of administration were not reported). No adverse effects were reported and no product quality complaint (PQC) was involved. This is one of several reports from the same reporter. Additional information has been requested.
HPV 9 given, fever and vomiting for a few weeks after 2nd dose.
died; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP).  A patient (no qualifiers provided) received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose number unknown, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: DEATH (death), outcome "fatal". The patient date of death was unknown. The reported cause of death was "Unknown cause of death". It was not reported if an autopsy was performed.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.; Reported Cause(s) of Death: Unknown cause of death
Information has been received via a company representative who saw on a television news channel a mother who reported an AE on behalf of her 15 year old daughter. The patient developed headache and meningitis symptoms after getting GARDASIL. Lot# was not provided. The patient's headache and meningitis symptoms persisted at the time of the report. No further information is available.  01/14/09 Reviewed Neurology medical records of 10/24-11/04/2008. FINAL DX: pseudotumor cerebri; headaches Records reveal patient experienced severe frontal HA, blurry vision, decreased concentration x 3 days.  Neuro exam revealed florid bilateral papilledema & upgoing toes.  Developed spells of neck & extremities stiffness.  Tx w/high dose steroids, antiseizure meds & diuretic.  RTC 11/4/08 much improved, HA resolved.  Revealed that pt had started minocycline for acne on same day as HPV vax given.
headache; muscle pain; felt exhausted; body hurt; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (headache), MYALGIA (muscle pain), FATIGUE (felt exhausted) and PAIN (body hurt) in a 24-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 007M201A and 001A21A) for COVID-19 vaccination.     No Medical History information was reported.   On 30-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 27-Feb-2021, the patient experienced HEADACHE (headache), MYALGIA (muscle pain), FATIGUE (felt exhausted) and PAIN (body hurt). The patient was treated with IBUPROFEN at an unspecified dose and frequency. At the time of the report, HEADACHE (headache), MYALGIA (muscle pain), FATIGUE (felt exhausted) and PAIN (body hurt) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (headache), MYALGIA (muscle pain), FATIGUE (felt exhausted) and PAIN (body hurt) in a 24-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 007M201A and 001A21A) for COVID-19 vaccination.  Concomitant medication include Birth control medicines    The patient's past medical history included No adverse event. Concomitant products included ORAL CONTRACEPTIVES for an unknown indication.   On 30-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 27-Feb-2021, the patient experienced HEADACHE (headache), MYALGIA (muscle pain), FATIGUE (felt exhausted) and PAIN (body hurt). The patient was treated with IBUPROFEN at an unspecified dose and frequency. At the time of the report, HEADACHE (headache), MYALGIA (muscle pain), FATIGUE (felt exhausted) and PAIN (body hurt) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Patient reported developing a rash on left arm which was descending down arm. Rash developed 3 days after vaccine administration. Patient was called to follow up and reported that rash resolved without an intervention.
A report was received from a health care professional on 22 October 2003 concerning a 65-year-old male vaccinee who experienced shortness of breath, dizziness, nausea and blurred vision 1 hour after receiving Fluvirin on 22 October 2003. On 22 October 2003 the vaccinee experienced shortness of breath, dizziness, nausea, and blurred vision. The vaccinee was taken to an emergency room for the management of events. It was unknown at the time of the report whether or not the vaccinee was admitted to hospital. There was insufficient information to determine the reporter's causality assessment. Follow up pending. Update 1, 10 December 2003: Following medical review on 10 December 2003, this case was considered to be medically significant (OMIC).
Uncontrollable blood pressure  , ongoing  Numbness in legs. Shingles outbreak
felt low blood pressure; weak; confused; When fell hit self on head, lip, nose, and eye; When fell hit self on head; bruises on face; had burst lip; diarrhea; leg pain; fainted; seizure; felt hot; chills/shaking.; This is a spontaneous report from a contactable consumer (patient herself).  This 62-year-old female patient (not pregnant) received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Lot number not provided), via an unspecified route of administration in the left arm, on 13Apr2021 at 21:00 (at the age of 62-year-old) as single dose for COVID-19 immunisation. Historical vaccine includes the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Lot number EP6775 MS 389) administered via an unknown route in the left arm on 17Mar2021 (at 10:00 AM) for COVID-19 immunisation. No other vaccine was received in four weeks. Relevant medical history included gastritis and anxiety. Past drug history included allergy to mirtazapine (REMERON). Relevant concomitant medications included diazepam (VALIUM), vitamins and probiotics. On 13Apr2021 at 23:00 the patient had chills / shaking. On 14Apr2021 at 02:00 AM, she felt hot. She went to bathroom, felt low blood pressure, weak, and fainted. Woke up, felt disoriented, not know where she was, confused. When fell hit self on head, lip, nose, and eye. She suffered various bruises on face. May have had seizure, had burst lip and felt was biting. Then suffered diarrhea that day. She also  experienced leg pain. She went to the doctor on 16Apr2021. On unknown date, blood work up was done and results were not provided. The patient was recovering from the events.  Information on the lot/batch number has been requested.
2021 - patient received vaccine primary doses 2023 -  COVID-19 hospitalization and death
Headache/second day third day headache tired eating better tired fourth day night sweats headache tired.; Chills; body aches; Fever; sweating/second day third day headache tired eating better tired fourth day night sweats; not eating/second day third day headache tired eating better; shaking; tired all on first day and second day third day headache tired eating better tired fourth day night sweats headache tired.; This is a spontaneous report from a contactable consumer (patient). A 51-year-old non-pregnant female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation solution for injection, Batch/LOT: unknown), via unspecified route of administration on unspecified date in Feb2021 4:30 PM (at the age of 51-year-old) on left arm as a DOSE 1, SINGLE for COVID-19 immunization. Patient medical history and concomitant medication were not reported. Patient had not received any other vaccine in four weeks and patient had not received any other medications in two weeks. Patient had no known allergies. Patient does not have covid prior vaccination and was not tested to covid post vaccination. on unspecified date in Feb2021 4:30 PM patient experienced headache chilled body aches fever shaking not eating sweats tired all on first day and second day third day headache tired eating better tired fourth day night sweats headache tired. Patient had not received any treatment for the events. Outcome of the events was not recovered.  Information about lot/Batch number has been requested.  Follow-up attempts completed. No further information expected.
A report was received from a health care professional on 11/26/03 concerning a 3 year old female vaccinee who was inadvertently administered Fluvirin vaccine 11/26/03. On 11/26/03, the vaccinee was administered 0.25ml Fluvirin. No adverse effects were reported at the time of the report. There was insufficient information to determine the reporter's causality assessment. Follow up pending.
Frontal headache lasting about twenty minutes.  Later that night, about 4 hours after receiving the vaccine, I experienced mild wheezing for less than 5 minutes, but believe this was likely due to allergies and associated postnasal drip rather than the vaccine.  The following day I had mild muscle soreness and injection site pain without swelling or redness.